The Median Effective Concentration of Sevoflurane for I‐Gel Laryngeal Mask Insertion in Unpremedicated Children Aged 1–10 Years: A Prospective Concentration‐Finding Study

Read full text Summarise with VIRAT
Authors: Zhengwei Gan, Shangyingying Li, Shun Yang, Li Liu, 茜予 邓, Yaqiong Tian, Li Yang, Fei Yang, Shengfen Tu
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The minimum alveolar concentration of sevoflurane varies with age in children, and the median effective concentration (EC 50 ) of sevoflurane for I‐gel insertion in children of different ages has not been reported. The aim of this study was to determine the EC 50 of end‐tidal sevoflurane maintained for 2.5 min for I‐gel insertion in children aged 1–10 years and also to estimate the 95% effective concentration (EC 95 ) . This study aimed to recruit children who were scheduled to undergo laparoscopic high ligation of the inguinal hernia sac or laparoscopic high ligature of the sheath process. Children were stratified into three age groups. We employed Dixon's up‐and‐down method in this study. The target end‐tidal sevoflurane concentration was then maintained at 2% for 2.5 min for the first child. The concentration for the subsequent patient was determined based on the response of the previous patient, with adjustments of 0.2%. This study was terminated when seven crossover points were reached. In the 1–3‐year‐old group including 3‐year‐old, EC 50 was 1.75% (95% confidence interval [CI], 1.72%–2.03%), and EC 95 was 2.17% (95% CI, 1.96%–2.18%). In the 3–6‐year‐old group including 6‐year‐old, EC 50 was 1.60% (95% CI, 1.35%–1.83%), and EC 95 was 1.96% (95% CI, 1.77%–1.98%). In the 6–10‐year‐old group, EC 50 was 0.96% (95% CI, 0.93%–2.20%) and EC 95 was 2.36% (95% CI, 2.15%–2.38%). Our study determined the EC 50 of end‐tidal sevoflurane required for I‐gel insertion in unpremedicated children aged 1–10 years and the results demonstrate to be both safe and effective for pediatric patients.

Fields of Study & Subjects

Anesthesia and Sedative Agents Airway Management and Intubation Techniques Anesthesia and Pain Management

Publication details

Journal / source
Pediatric Discovery
Volume
4
Issue
1
Pages
e70039–e70039
Publication date
1 March 2026
Language
EN